Sep 2026· Orphanet Journal of Rare Diseases· 0 citations
TL;DR
The available case reports highlight marked clinical heterogeneity in carnosinemia, ranging from severe neurodevelopmental phenotypes to asymptomatic biochemical abnormalities, which underscores the need for improved phenotypic characterization, systematic follow-up, and international case registries.
Abstract
Carnosinemia, also referred to as carnosinase 1 (CNDP1) deficiency, is an ultra-rare inborn error of metabolism characterized by impaired CNDP1 activity and carnosine degradation. The clinical significance and phenotypic spectrum of this condition remain poorly defined, with highly heterogeneous neurological and developmental manifestations reported in the literature. This systematic review aims to characterize the clinical, biochemical, and genetic spectra of carnosinase deficiency based on published case reports. Following PRISMA guidelines, case reports and case series were identified through PubMed (MEDLINE), Embase (OVID), and Web of Science from inception to 2025. Eligible studies included cases with biochemical evidence of serum carnosinase deficiency and available genetic or cytogenetic investigations. Data on demographic characteristics, clinical presentation, biochemical findings, genetic variants, management, and outcomes were extracted and synthesized qualitatively. A total of 9 articles were included. Most patients presented in infancy or early childhood, although asymptomatic or mildly affected individuals were also reported. Neurological manifestations were the most frequent clinical features, including developmental delay, hypotonia, seizures, and ataxia, while a subset of cases showed minimal or no overt neurological impairment. Biochemically, elevated plasma and urinary carnosine (carnosinuria) levels with reduced or absent serum carnosinase activity were consistently observed. Management strategies were largely supportive and heterogeneous, including dietary restriction of carnosine-rich foods in some cases, with no standardized therapeutic approach. Long-term follow-up data were limited; however, outcomes ranged from stable neurological function to persistent neurodevelopmental impairment. The available case reports highlight marked clinical heterogeneity in carnosinemia, ranging from severe neurodevelopmental phenotypes to asymptomatic biochemical abnormalities. The absence of consistent genotype–phenotype correlations and standardized management strategies underscores the need for improved phenotypic characterization, systematic follow-up, and international case registries. Future studies are required to clarify the true clinical relevance of carnosinemia and to define evidence-based diagnostic and management pathways.
Cobalamin is essential for DNA synthesis and for methylmalonyl-CoA mutase and methionine synthase activity. Inherited disorders of intracellular cobalamin (Cbl) metabolism are single-gene defects affecting absorption, transport, or intracellular processing, with variable phenotypes depending on the severity and l...
A. Al Shamsi, Omar Abuhaltem· Orphanet Journal of Rare Dis...· 0 citations
BACKGROUND
Severe free carnitine deficiency (C0 ≤5 μmol/L) is frequently observed in pediatric patients suspected of primary carnitine deficiency (PCD), though confirmed diagnoses remain rare. This study aimed to analyze the disease spectrum and genetic profile of high-risk children with severe reduced carnitine levels...
Jing Liu, Zhen-Hua Xie, Meng-Jun Xiao et al.· Pediatrics and Neonatology· 0 citations
The cohort highlights novel findings, including the co-occurrence of AD LZTR1-NS with 22q11.2 deletion and two patients with AR NS with features suggestive of schwannomatosis, which expand the clinical spectrum of LZTR1-NS and have important implications for diagnosis, surveillance, and genetic counseling.
H. Jaouadi, Şakir Hicazi, Carolyn R. Raski et al.· American Journal of Medical...· 0 citations
HMGCS2 deficiency, BKTD, and SCOT deficiency show overlapping features but can be distinguished by ketone levels, glucose patterns, and acylcarnitine profiles.
Burcu Koseci, Ezgi Burgaç, Ahmet Yöntem et al.· Journal of Pediatric Endocri...· 0 citations
Introduction: Cohen syndrome (CS) is a rare autosomal recessive multisystem disorder caused by biallelic pathogenic variants in the VPS13B gene. Although the neurodevelopmental and dysmorphic manifestations of the disease are well characterized, its immunological features remain insufficiently defined. This study aimed...
Yahya Gul, Akçahan Akalın, S. Samancı· Family Practice and Palliati...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.